MedPath

Effect of add-on medication (with dose increase, combined with anti-leukotriene , combined with steroid nasal spray)for allergic rhinitis patients who are not effective of normal dose of Bepotastine besilate .

Phase 2
Conditions
allergic rhinitis
Registration Number
JPRN-UMIN000011336
Lead Sponsor
Graduate Scool of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Patients judged inappropriate for this study by the physicians

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assesment of symptom after as below for the allergic rhinitis patients . Allergic rhinitis patients are separeted 3groups(dose increase,combined with anti-luekotriene, combined with steroid nasal spray) ,and carry on for 4 week. Assesment:medical examination at the department of otorhinolaryngology with a disease questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath